August 6, 2024 – Talk Bio

Mallinckrodt, Therakos, CVC Capital Partners, photopheresis, extracorporeal photopheresis, ECP, cutaneous T-cell lymphoma, CTCL, immunotherapy, pharmaceuticals, medical technology, healthcare services

Symbiotic Capital Launches with $600M, Ties to Arie Belldegrun’s Bellco

9 months ago talkbio0Tagged Arie Belldegrun, Bellco, Capital, Credit - Transaction Type, Firm, Private Equity, Symbiotic

Symbiotic Capital, Arie Belldegrun, Bellco, $600M, credit firm, biotech, private equity

Bayer Announces 3,200 Job Cuts, Highlights Progress in Pharmaceutical Pipeline

9 months ago talkbio0Tagged Bayer, Financial cost, Financial savings, Organization administrative structures, pharmaceutical pipeline

Bayer, job cuts, pharmaceutical pipeline, cost savings, organizational restructuring

Merck and Daiichi Sankyo Collaborate to Develop T-Cell Engager MK-6070 from Harpoon Acquisition

9 months ago talkbio0Tagged Antibody-Drug, Daiichi, DLL3 gene, Harpoon, Immunostimulating conjugate (antigen), Merck, MK-6070, Sankyo, Small cell carcinoma of lung, T-Lymphocyte

Merck, Daiichi Sankyo, T-cell engager, MK-6070, Harpoon Therapeutics, small cell lung cancer, DLL3, antibody-drug conjugates

FDA Approves First Engineered T Cell Therapy for Solid Tumors, Expands GSK’s Jemperli

9 months ago talkbio0Tagged Approved, dostarlimab-gxly, Engineer, GSK 's, Jemperli, Malignant neoplasm of endometrium, Solid Neoplasm, synovial sarcoma, T cell therapy, Tecelra, United States Food and Drug Administration

FDA approval, engineered T cell therapy, solid tumors, GSK’s Jemperli, dostarlimab-gxly, afamitresgene autoleucel, Tecelra, endometrial cancer, synovial sarcoma